Latest news and events

Latest News from the Partnership

Barbara Sixt (second from left) with her research group at MIMS. Photo: MIMS

2019.05.29 | People

Introducing MIMS-EMBL group leaders: Barbara Sixt, Cell-autonomous immunity

Over the past 12 months, MIMS has recruited five new group leaders. Here, we meet Barbara Sixt, who joined MIMS as a Group Leader in May 2018. Dr. Sixt has already started to build up her group, with plans to further expand her team. The next year will see her focus on getting her research programme going.

Dr Björn Schröder. Photo: Christopher Coe
Fig 1. From: Schroeder BO, Gastroenterology Report 7(1), 2019, 3–12

2019.05.21 | Research news

Introducing MIMS-EMBL group leaders: Björn Ole Schröder - Gut microbiota and intestinal mucosal barrier function

Over the past 12 months, MIMS has recruited five new group leaders. In this interview series, we profile each new group leader and detail their research interests and hopes for their time at MIMS. Here, we introduce Björn O Schröder, who joined MIMS in April 2019.

The Nordic EMBL Partnership directors. (Left to right) Janna Saarela, Mark Daly, EMBL Director General Edith Heard, former EMBL Director General Iain Mattaj, Poul Nissen, Oliver Billker. Photo: Massimo del Prete/EMBL

2019.04.12 | People

Partners in the North

EMBL's 'Lab Matters' series profiles Nordic EMBL Partnership Directors

Dr. Emma Haapaniemi. Photo: Matti Immonen

2019.04.02 | Research news

Welcome to: Emma Haapaniemi, Group Leader, NCMM

Dr Emma Haapaniemi joined NCMM as a group leader in January 2019. Her research programme will focus on rare immune diseases caused by genetics and rare acquired autoimmune diseases.

Keisuke Yonehara. Photo: Annabel Darby
The Yonehara Lab Photo: Annabel Darby

2019.03.29 | Research news

Behind the Scenes: Keisuke Yonehara, Group Leader, DANDRITE

Keisuke Yonehara is head of the Spatially Asymmetric Neural Circuits in Visual System group at DANDRITE. He recently had his group leader position extended for a further four years. In our latest Behind the Scenes article, Dr Yonehara discusses his research and how made the move from veterinary science to neuroscience.

The Chemical Biology Screening team (from left to right - Alexandra Gade, Eirin Solberg, and Johannes Landskron) Photo: Nadia Frantsen

2019.03.15 | News from the management

Behind the Scenes: The Chemical Biology Platform at NCMM

Johannes Landskron, Head of the Chemical Biology Platform at NCMM, shares some insight into how the platform works, and why it is so important for researchers.

Jing Tang (third from left) and the iCombine Team, winners of the Helsinki Challenge. Photo: Jing Tang

2019.03.15 | People , News from the management

Behind the Scenes: Jing Tang, Group Leader, FIMM

Jing Tang joined FIMM as a senior researcher in Tero Aittokallio’s group in 2012. Here he shares some background on his career and research to date.

Image Caption

2019.03.15 | Research news

First common risk genes discovered for autism

An international research team involving scientists from FIMM has found the first common genetic risk variants for autism.

Professor Janna Saarela. Photo: Kirsi Tuura, University of Helsinki

2019.02.08 | People

Welcome to: Professor Janna Saarela

Professor Janna Saarela officially started as Director of NCMM in January 2019. She joins NCMM from the Nordic EMBL's Finnish partner, FIMM. Here she shares some insight into her research, and her vision for the future of NCMM.

2019.01.21 | Research news

GSK and Sanofi join FinnGen study

GSK and Sanofi have joined the FinnGen study, a large public-private partnership aiming to collect and analyse genome and health data from 500 000 Finns and thereby generate novel medically and therapeutically relevant insights.

Showing results 11 to 20 of 31

Previous 1 2 3 4 Next

Upcoming Partnership Events

News on publications